Clinical and preclinical studies have demonstrated that elevated levels of circulating inflammatory cytokines, such as Interleukin-6 (IL-6), Interleukin-1 beta (IL-1β), and Tumor Necrosis Factor-alpha (TNF-α), correlate with AF burden and recurrence (9). This evidence concerns the gene IL1B and atrial fibrillation.